Skip to main content
. 2016 Feb 2;37(18):1449–1455. doi: 10.1093/eurheartj/ehv743

Figure 1.

Figure 1

Distribution of therapy. The Figure illustrates that overall 57.5% of patients were treated with at least one disease targeting therapy drug. Of those patients treated with disease targeting therapies, over 95% of patients were on Bosentan or Sildenafil.